These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 28458514)
1. Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension. Lian TY; Jiang X; Jing ZC Drug Des Devel Ther; 2017; 11():1195-1207. PubMed ID: 28458514 [TBL] [Abstract][Full Text] [Related]
2. The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension. DeSouza SA; Preston IR Expert Rev Cardiovasc Ther; 2015 May; 13(5):467-76. PubMed ID: 25797801 [TBL] [Abstract][Full Text] [Related]
3. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Mielniczuk LM; Swiston JR; Mehta S Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043 [TBL] [Abstract][Full Text] [Related]
4. Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension. Ghofrani HA; Humbert M; Langleben D; Schermuly R; Stasch JP; Wilkins MR; Klinger JR Chest; 2017 Feb; 151(2):468-480. PubMed ID: 27263466 [TBL] [Abstract][Full Text] [Related]
5. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Bishop BM Am J Health Syst Pharm; 2014 Nov; 71(21):1839-44. PubMed ID: 25320133 [TBL] [Abstract][Full Text] [Related]
6. Riociguat: first global approval. Conole D; Scott LJ Drugs; 2013 Nov; 73(17):1967-75. PubMed ID: 24218053 [TBL] [Abstract][Full Text] [Related]
7. Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension. Belik J Curr Opin Investig Drugs; 2009 Sep; 10(9):971-9. PubMed ID: 19705340 [TBL] [Abstract][Full Text] [Related]
9. Riociguat: a novel new drug for treatment of pulmonary hypertension. Makowski CT; Rissmiller RW; Bullington WM Pharmacotherapy; 2015 May; 35(5):502-19. PubMed ID: 26011143 [TBL] [Abstract][Full Text] [Related]
10. Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Dasgupta A; Bowman L; D'Arsigny CL; Archer SL Clin Pharmacol Ther; 2015 Jan; 97(1):88-102. PubMed ID: 25670386 [TBL] [Abstract][Full Text] [Related]
11. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension. Garnock-Jones KP Drugs; 2014 Nov; 74(17):2065-78. PubMed ID: 25352393 [TBL] [Abstract][Full Text] [Related]
12. Riociguat for the treatment of pulmonary hypertension. Meis T; Behr J Expert Opin Pharmacother; 2014 Nov; 15(16):2419-27. PubMed ID: 25260791 [TBL] [Abstract][Full Text] [Related]
13. Riociguat for the treatment of pulmonary hypertension. Hambly N; Granton J Expert Rev Respir Med; 2015; 9(6):679-95. PubMed ID: 26599488 [TBL] [Abstract][Full Text] [Related]
14. [Riociguat: stimulator of soluble guanylate-cyclase. New mode of action for the treatment of pulmonary arterial and non operable chronic thromboembolic pulmonary hypertension]. Leuchte HH; Behr J; Ewert R; Ghofrani HA; Grünig E; Halank M; Held M; Klose H; Rosenkranz S; Schermuly RT; Wilkens H; Hoeper MM Pneumologie; 2015 Mar; 69(3):135-43. PubMed ID: 25750094 [TBL] [Abstract][Full Text] [Related]
15. Riociguat for the treatment of pulmonary hypertension. Schermuly RT; Janssen W; Weissmann N; Stasch JP; Grimminger F; Ghofrani HA Expert Opin Investig Drugs; 2011 Apr; 20(4):567-76. PubMed ID: 21391889 [TBL] [Abstract][Full Text] [Related]
16. Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP? Koress C; Swan K; Kadowitz P Curr Hypertens Rep; 2016 Apr; 18(5):42. PubMed ID: 27118316 [TBL] [Abstract][Full Text] [Related]
17. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study. Halank M; Hoeper MM; Ghofrani HA; Meyer FJ; Stähler G; Behr J; Ewert R; Fletcher M; Colorado P; Nikkho S; Grimminger F Respir Med; 2017 Jul; 128():50-56. PubMed ID: 28610669 [TBL] [Abstract][Full Text] [Related]
18. Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat. Frey R; Becker C; Saleh S; Unger S; van der Mey D; Mück W Clin Pharmacokinet; 2018 Jun; 57(6):647-661. PubMed ID: 29086344 [TBL] [Abstract][Full Text] [Related]
19. [The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat]. Gratsianskaya SE; Valieva ZS; Martynyuk TV Ter Arkh; 2020 Oct; 92(9):77-84. PubMed ID: 33346435 [TBL] [Abstract][Full Text] [Related]
20. Treatment of pulmonary hypertension with riociguat: a review of current evidence and future perspectives. Boutou AK; Pitsiou G Expert Opin Pharmacother; 2020 Jul; 21(10):1145-1155. PubMed ID: 32089012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]